218 results
8-K
EX-99.1
RGEN
Repligen Corp.
19 Mar 24
Repligen Appoints Maggie A. Pax to Board of Directors
7:41am
Scientific, where, from 2016–2020, she served as Vice President, Strategy and Innovation for the clinical supply chain business. In this role, she … &A integration. We look forward to her involvement and input.”
In addition to her role as Vice President Strategy and Innovation at Thermo Fisher, Ms. Pax’s
8-K
EX-99.1
RGEN
Repligen Corp.
21 Sep 12
Repligen Appoints Jonathan I. Lieber as CFO
12:00am
financial activities, including long-term financial strategy and risk management. Repligen’s current CFO William J. Kelly has been named Chief Accounting … as we advance on our strategy to further expand Repligen’s bioprocessing business and deliver top-tier financial performance.”
During his three-year
8-K
EX-99.1
RGEN
Repligen Corp.
2 Aug 12
Reports Second Quarter 2012 Financial Results
12:00am
that it will focus its corporate strategy and resources on the growth of its core bioprocessing business, which achieved record sales during the quarter. As a result … , and the continued strength in the global market for biologic drugs were key factors in our decision to focus corporate strategy and resources on bioprocessing. We
DEF 14A
EX-99
RGEN
Repligen Corp.
22 Aug 95
Definitive proxy
12:00am
with a scarcity of new capital, motivated us to
review the business strategy outlined in last year's annual report. The current
business environment combined … form of
rPF4. The long-term strategy of this SBU is to rebuild our research effort by
partnering at least one of our technology platforms. As funding
8-K
EX-99.1
RGEN
Repligen Corp.
8 Aug 07
Repligen Reports First Quarter Fiscal Year 2008 Financial Results
12:00am
of Repligen Corporation. “We continue to execute on our strategy to build shareholder value through prudent business management in which the growing … and position, management's strategy, plans and objectives for future operations, plans and objectives for product development, plans and objectives for present
8-K
EX-99.1
inf4ivmnfv6o9 cr33r
25 May 05
Repligen Reports Fourth Quarter and Fiscal Year 2005 Financial Results
12:00am
8-K
EX-99.1
2gzbd
27 Jul 05
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
u7pjaq
5 Jan 04
Other events
12:00am
8-K
EX-99.1
tohfpl7p x5zqrchjba
11 Jun 09
Repligen Reports Fourth Quarter and Fiscal Year 2009 Financial Results
12:00am
8-K
EX-99.1
xd4q4 40qm
12 Jun 08
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
ykwmrnlp
7 Jun 07
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
5gs8 x3ulxtwcmfo0x
12 Nov 03
Current Report
12:00am
8-K
EX-99.1
opx3inmx7ut
5 Oct 11
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
87ozdc
9 Jun 11
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
eeni3vkr65sd54 z2
8 Aug 06
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
5b3gy8yhm1x0 ykt
8 Feb 07
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
fgm8uyvq6qnblq
9 Feb 06
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
iuhxqswyurhcl
26 Apr 19
Repligen Corporation Announces Agreement to Acquire Process Analytics Innovator
7:45am